Vladimir Pisevski, ReVitt A user. Diagnosed with Myeloma, type IGG. 2017
“Within two months of regularly using Revitt A (two in the morning, one at night) my disease markers were in the normal range, and blood counts suggested remission of the disease.
In general, I feel better and more energized, and I am much less susceptible to infections. I still take the same amount and plan to take it the future, and as I am very pleased with the results.
I would recommend it to anyone with similar issues.”